The PD-L1-high-actived group demonstrated the most SNV neoantigens and highest nonsilent mutation rate, in agreement with recent research suggesting that patients with high neoantigen number and high mutation rate exhibit the longest survival in bladder cancer. Here, CD274 is linked to urinary bladder carcinoma.